Third blank check company formed by Casdin Capital and Corvex Management targeting a life science business (completed 12/17/2021).
Industry: SPAC
First Day Return: +11.9%
Industry: SPAC
IPO Data | |
---|---|
IPO File Date | 02/25/2021 |
Offer Price | $10.00 |
Price Range $10.00 - $10.00 | |
Offer Shares (mm) | 48.0 |
Deal Size ($mm) | $480 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/06/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $480 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2021 |
Employees at IPO | 3 |